(Q43755070)

26 November 2017

Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential (English)

1 reference

26 November 2017

Andrew Wiley

1

1 reference

26 November 2017

Dionyssios Katsaros

2

1 reference

26 November 2017

Haigang Chen

3

1 reference

26 November 2017

Irene A Rigault de la Longrais

4

1 reference

26 November 2017

Alicia Beeghly

5

1 reference

26 November 2017

Manuela Puopolo

6

1 reference

26 November 2017

Rakesh Singal

7

1 reference

26 November 2017

Yan Zhang

8

1 reference

26 November 2017

Agyenim Amoako

9

1 reference

26 November 2017

Daniel Zelterman

10

1 reference

26 November 2017

Herbert Yu

11

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 July 2006

1 reference

26 November 2017

1 reference

26 November 2017

107

1 reference

26 November 2017

299-308

1 reference

26 November 2017

2

1 reference

Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes

26 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

21 January 2018

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

Frequency of symptoms of ovarian cancer in women presenting to primary care clinics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

DNA methylation of nuclear receptor genes--possible role in malignancy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

Aberrant DNA methylation as a cancer-inducing mechanism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

CpG island methylator phenotype in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

CpG island methylator phenotype in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

Detection of hypermethylated genes in women with and without cervical neoplasia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

DNA methylation and ovarian cancer. I. Analysis of CpG island hypermethylation in human ovarian cancer using differential methylation hybridization.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

Mechanisms underlying lack of insulin-like growth factor-binding protein-3 expression in non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

Methylation of the insulin-like growth factor binding protein-3 gene and prognosis of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

Carcinoma of the ovary

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

Aging, DNA methylation and cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

Epigenetic variation and human disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

The fundamental role of epigenetic events in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

Epigenetic gene silencing in cancer initiation and progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

DNA hypermethylation in tumorigenesis: epigenetics joins genetics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

Tumor Cell-SpecificBRCA1andRASSF1AHypermethylation in Serum, Plasma, and Peritoneal Fluid from Ovarian Cancer Patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

Differences in p16 gene methylation and expression in benign and malignant ovarian tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

Promoter hypermethylation profile of ovarian epithelial neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

Estrogens and epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

Estrogen and progesterone receptors in ovarian epithelial tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

Number of CpG islands and genes in human and mouse

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21992

7 January 2021

Identifiers

DOI

10.1002/CNCR.21992

1 reference

26 November 2017

1 reference